Saturday 25 February 2012

Top 20 Global Therapeutic Classes, 2010, Total Audited Markets, IMS data


2010 rank (US$)
2010 Sales (US$ MN)
% Growth 2010 (LC$)
2009 Sales (US$ MN)
% Growth 2009 (LC$)
2008 Sales (US$ MN)
% Growth 2008 (LC$)
2007 Sales (US$ MN)
Global Market
0
791,449$
5.2
752,022$
6.7
727,067$
5.0
671,164$
Oncologics
1
55,972$
6.7
52,372$
8.8
49,438$
13.4
41,949$
Lipid Regulators
2
36,400$
2.0
35,281$
4.9
34,445$
(1.2)
34,141$
Respiratory Agents
3
35,926$
7.0
33,596$
11.0
31,186$
5.9
28,775$
Antidiabetics
4
34,429$
12.2
30,406$
13.4
27,548$
10.1
24,401$
Anti-ulcerants
5
27,972$
(6.5)
29,610$
0.6
30,032$
0.0
29,174$
Angiotensin II Antagonists
6
26,630$
4.5
25,209$
11.5
22,998$
13.3
19,418$
Antipsychotics
7
25,412$
9.0
23,248$
4.6
22,742$
7.7
20,693$
Autoimmune agents
8
20,710$
14.7
17,961$
18.0
15,612$
19.3
12,815$
Antidepressants
9
20,216$
3.4
19,416$
(1.3)
20,194$
1.1
19,581$
HIV Antivirals
10
15,432$
13.2
13,758$
14.9
12,280$
12.7
10,699$
Platelet Aggr. Inhibitors
11
15,244$
1.8
14,604$
9.0
13,647$
10.4
11,952$
Vitamins & minerals
12
12,971$
6.1
11,951$
9.5
11,374$
8.7
10,109$
Anti-epileptics
13
12,553$
(3.3)
12,995$
(19.8)
16,792$
9.8
15,136$
Narcotic analgesics
14
12,011$
6.4
11,235$
8.6
10,534$
8.9
9,530$
Cephalosporins & combs
15
11,466$
6.1
10,586$
6.9
10,188$
3.4
9,489$
Non-Narcotic Analgesics
16
10,986$
0.0
10,917$
7.5
10,896$
4.2
10,179$
Vaccines
17
10,972$
2.8
10,690$
(1.6)
11,172$
(0.6)
10,911$
Erythropoietins
18
10,596$
(2.3)
10,829$
(4.1)
11,486$
(13.0)
12,866$
Anti-Rheumatics, Non-Steroidal
19
10,152$
3.6
9,668$
3.0
9,897$
3.6
9,318$
Multiple Sclerosis
20
9,844$
13.8
8,712$
16.8
7,716$
19.9
6,245$
Posted by
Labels: , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)